Amyris Announces Key Advancements Under DARPA Multi-Year Technology Investment Agreement — Enables Development of Industrial-Scale Fermentation Process For Virtually Any Biological Molecule
(Amyris) Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has successfully expanded its world-class expertise in strain engineering and optimization to 26 key metabolic precursors across multiple organisms, as part of its Technology Investment Agreement (TIA) with